This content is only available within our institutional offering.
10 Aug 2017
A watershed moment for CAR-T
Advanced Medical Solutions Group plc (AMS:LON), 182 | Allergy Therapeutics plc (AGY:LON), 2.7 | Animalcare Group PLC (ANCR:LON), 211 | C4X Discovery Holdings Plc (C4XD:LON), 13.5 | Consort Medical (CSRT:LON), 0 | EKF Diagnostics Holdings plc (EKF:LON), 26.6 | Faron Pharmaceuticals Oy (FARN:LON), 182 | ImmuPharma plc (IMM:LON), 2.0 | MaxCyte, Inc. (MXCT:LON), 328 | ProMetic Life Sciences (PLI:TSE), 0 | Scancell Holdings Plc (SCLP:LON), 10.2 | Sphere Medical Holding (SPHR:LON), 0 | Venture Life Group Plc (VLG:LON), 36.0 | HUTCHMED (China) Limited (HCM:LON), 0 | BTG Hotels (Group) Co Ltd Shs -A- (600258:SHG), 0 | VERBUND AG Class A (0NR1:LON), 0 | Biodexa Pharmaceuticals plc Sponsored ADR (BDRX:NAS), 0
Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
A watershed moment for CAR-T
Advanced Medical Solutions Group plc (AMS:LON), 182 | Allergy Therapeutics plc (AGY:LON), 2.7 | Animalcare Group PLC (ANCR:LON), 211 | C4X Discovery Holdings Plc (C4XD:LON), 13.5 | Consort Medical (CSRT:LON), 0 | EKF Diagnostics Holdings plc (EKF:LON), 26.6 | Faron Pharmaceuticals Oy (FARN:LON), 182 | ImmuPharma plc (IMM:LON), 2.0 | MaxCyte, Inc. (MXCT:LON), 328 | ProMetic Life Sciences (PLI:TSE), 0 | Scancell Holdings Plc (SCLP:LON), 10.2 | Sphere Medical Holding (SPHR:LON), 0 | Venture Life Group Plc (VLG:LON), 36.0 | HUTCHMED (China) Limited (HCM:LON), 0 | BTG Hotels (Group) Co Ltd Shs -A- (600258:SHG), 0 | VERBUND AG Class A (0NR1:LON), 0 | Biodexa Pharmaceuticals plc Sponsored ADR (BDRX:NAS), 0
- Published:
10 Aug 2017 -
Author:
Dr Julie Simmonds -
Pages:
30